Literature DB >> 6969226

T-cell-mediated cytotoxic response to mumps virus in humans.

H Tsutsumi, Y Chiba, W Abo, S Chiba, T Nakao.   

Abstract

Mumps-specific T-cell-mediated cytotoxic activity against virus-treated autologous lymphocytes was studied after peripheral blood lymphocytes of sensitized subjects had been incubated with ultraviolet light-inactivated virus antigen. Generation of the cytotoxic activity in vitro was associated with an antecedent lymphoproliferative response to mumps virus. The virus specificity of the effector cells was demonstrated by a lack of lysis of type 1 parainfluenza virus (HVJ)-treated as well as of type A influenza virus-treated autologous target cells. This activity was largely associated with E-rosette-forming T lymphocytes as revealed by negative selection of a population from cultured whole lymphocytes. In addition, sequential investigations for subjects with a natural mumps virus infection clearly demonstrated individual characteristics of the cytotoxic response. Therefore, the assay described could be used to reflect mumps virus-specific T-cell-mediated immunity in humans.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969226      PMCID: PMC551286          DOI: 10.1128/iai.30.1.129-134.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.

Authors:  B Härfast; T Andersson; P Perlmann
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

2.  Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus.

Authors:  U Koszinowski; H Ertl
Journal:  Nature       Date:  1975-06-12       Impact factor: 49.962

3.  Immunologic significance of the mumps virus skin test in infants, children and adults.

Authors:  J W Geme; T Yamauchi; E J Eisenklam; G R Noren; J M Aase; R B Jurmain; R M Henn; M C Gabel; A W Hollister; R Paumier
Journal:  Am J Epidemiol       Date:  1975-03       Impact factor: 4.897

4.  Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

5.  Live attenuated mumps virus vaccine. 1. Vaccine development.

Authors:  E B Buynak; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1966-12

6.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

7.  An immuno-cytopathogenic interaction between sensitized leukocytes and epithelial cells carrying a persistent noncytocidal myxovirus infection.

Authors:  L F Speel; J E Osborn; D L Walker
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

8.  The characteristics of lymphocyte tritiated thymidine incorporation in response to mumps virus.

Authors:  K A Smith; L Chess; M R Mardiney
Journal:  Cell Immunol       Date:  1972-12       Impact factor: 4.868

9.  An in vitro method for study of human lymphocyte cytotoxicity against mumps-virus-infected target cells.

Authors:  T Andersson; V Stejskal; B Harfast
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  3 in total

1.  In vitro secondary generation of cytotoxic T lymphocytes in mice with mumps virus and their mumps-specific cytotoxicity among paramyxoviruses.

Authors:  Y Hosaka; Y Yasuda; O Seriburi; M G Moran; K Fukai
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

2.  Human leukocyte antigen-linked genetic controls for T cell-mediated cytotoxic response to mumps virus in humans.

Authors:  Y Chiba; H Tsutsumi; T Nakao; A Wakisaka; M Aizawa
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

3.  Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.

Authors:  H Tsutsumi; J M Bernstein; M Riepenhoff-Talty; E Cohen; F Orsini; P L Ogra
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.